Search bioRxivSearch

Biology subjects

Pico, A. R.

Publications and source records attributed to Pico, A. R..

3 recordsLinked to original sources

Identifying Genes in Published Pathway Figure Images

BACKGROUNDPathway figures are commonly found in the biomedical literature providing intuitive models of complex processes in a visually concise format. The contents of a pathway figure often reflect the key findings and relevant context of an article. Unfortunately, the vast majority of pathway figures are drawn as one-off static images despite freely available pathway tools and resources, thus rendering their contents inaccessible to search, data mining and downstream analysis.\n\nAPPROACHLeveraging advances in optical character recognition and domain expertise in pathway modeling, we devised an approach to identify genes in published pathway figures. The approach was optimized against a set of figure images obtained from PubMed Central and tested against a set of 400 curated pathways with known content from WikiPathways (F-measure 95.2%).\n\nRESULTSApplied to 3982 published pathway figures spanning a four year period, our approach identified 29,189 gene symbols representing 4159 unique gene identifiers. The gene content unlocked from just this small sample of published figures includes novel and diverse pathway associations unmatched by any pathway database. Our approach over doubled the number of genes associated with the articles containing these figures as compared to combined annotations available from PubMed and PubTator. Encouraged by these initial results, we plan to scale the approach to make the molecular contents of the continuing stream of published pathway figures more accessible.

bioinformatics

ERNIE: A Data Platform for Research Assessment

Data mining coupled to network analysis has been successfully used to study relationships between basic discovery and translational applications such as drug development; and to document research collaborations and knowledge flows. Assembling relevant data for such studies in a form that supports analysis presents challenges. We have developed Enhanced Research Network Information Environment (ERNIE), an open source, scalable cloud-based platform that (i) integrates data drawn from public and commercial sources (ii) provides users with analytical workflows that incorporate expert input at critical stages. A modular design enables the addition, deletion, or substitution of data sources. To demonstrate the capabilities of ERNIE, we have conducted case studies that span drug development and pharmacogenetics. In these studies, we analyze data from regulatory documents, bibliographic and patent databases, research grant records, and clinical trials, to document collaborations and identify influential research accomplishments.

scientific communication and education

Research Synergy and Drug Development: Bright Stars in Neighboring Constellations

Drug discovery and subsequent availability of a new breakthrough therapeutic or cure is a compelling example of societal benefit from research advances. These advances are invariably collaborative, involving the contributions of many scientists to a discovery network in which theory and experiment are built upon. To understand such scientific advances, data mining of public and commercial data sources coupled with network analysis can be used as a digital methodology to assemble and analyze component events in the history of a therapeutic. This methodology is extensible beyond the history of therapeutics and its use more generally supports (i) efficiency in exploring the scientific history of a research advance (ii) documenting and understanding collaboration (iii) portfolio analysis, planning and optimization (iv) communication of the societal value of research. As a proof of principle, we have conducted a case study of five anti-cancer therapeutics. We have linked the work of roughly 237,000 authors in 106,000 scientific publications that capture the research crucial for the development of these five therapeutics. We have enriched the content of networks of these therapeutics by annotating them with information on research awards as well as peer review that preceded these awards. Applying retrospective citation discovery, we have identified a core set of publications cited in the networks of all five therapeutics and additional intersections in combinations of networks as well as awards from the National Institutes of Health that supported this research. Lastly, we have mapped these awards to their cognate peer review panels, identifying another layer of collaborative scientific activity that influenced the research represented in these networks.

scientific communication and education